Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints

Adaptive seamless design, which integrates phases II and III into a single trial comprising two stages, is garnering increasing interest in the efficient drug development. The first stage involves selecting promising treatment group(s), followed by comparing the efficacy between the selected and control groups in the second stage. This study focused on a two-stage adaptive seamless design where treatment selection is based on a short-term binary endpoint, while the comparison is based on a long-term binary endpoint. Recently, exact and mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> tests were proposed in this setting. However, treatment effects at the second stage were estimated using the conventional maximum likelihood estimator (MLE), leading to upward bias owing to treatment selection. We propose the conditional mean-adjusted estimator (CMAE) and uniformly minimum variance conditional unbiased estimator (UMVCUE) to address the bias in this setting. Additionally, confidence intervals for exact and mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> tests were constructed using the Clopper-Pearson method. Simulation studies were performed to compare the six inference methods defined by combinations of the three estimators and two statistical tests. The simulation results showed that MLE of the treatment effect at the second stage exhibited a notable bias, while CMAE and UMVCUE substantially reduced the bias. The exact test was conservative in terms of the type-I error rate of the comparison at the second stage, while the mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> test yielded results close to the nominal level. In conclusion, we recommend statistical inferences based on the CMAE + mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> test or UMVCUE + mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> test in our setting.

Authors

Institutions

Publication Details

Journal
Statistics in Medicine
Published
2025-03-06
DOI
https://doi.org/10.1002/sim.70003
Citations
1
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
2.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints

Kazushi Maruo, Ryota Ishii, Masahiko Gosho, Kenichi Takahashi
1 citations
Statistics in Medicine
Statistical Methods in Clinical Trials
2.63
article

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints

Kazushi Maruo, Ryota Ishii, Masahiko Gosho, Kenichi Takahashi
article en
1 citations

Abstract

Adaptive seamless design, which integrates phases II and III into a single trial comprising two stages, is garnering increasing interest in the efficient drug development. The first stage involves selecting promising treatment group(s), followed by comparing the efficacy between the selected and control groups in the second stage. This study focused on a two-stage adaptive seamless design where treatment selection is based on a short-term binary endpoint, while the comparison is based on a long-term binary endpoint. Recently, exact and mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> tests were proposed in this setting. However, treatment effects at the second stage were estimated using the conventional maximum likelihood estimator (MLE), leading to upward bias owing to treatment selection. We propose the conditional mean-adjusted estimator (CMAE) and uniformly minimum variance conditional unbiased estimator (UMVCUE) to address the bias in this setting. Additionally, confidence intervals for exact and mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> tests were constructed using the Clopper-Pearson method. Simulation studies were performed to compare the six inference methods defined by combinations of the three estimators and two statistical tests. The simulation results showed that MLE of the treatment effect at the second stage exhibited a notable bias, while CMAE and UMVCUE substantially reduced the bias. The exact test was conservative in terms of the type-I error rate of the comparison at the second stage, while the mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> test yielded results close to the nominal level. In conclusion, we recommend statistical inferences based on the CMAE + mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> test or UMVCUE + mid- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mi>p</mml:mi></mml:mrow> <mml:annotation>$$ p $$</mml:annotation></mml:semantics> </mml:math> test in our setting.

Statistics in MedicineVol. 44(6)
University of Tsukuba (JP), MSD K.K. (Japan) (JP)
Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 14%
Statistical Methods in Clinical Trials
2.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.